RT @RoswellPark: Congratulations to our own Dr. Puzanov, one of the senior authors on a paper that was awarded Best JITC Clinical/Translati…
100 followers
3,179 followers
20,224 followers
Congratulations to our own Dr. Puzanov, one of the senior authors on a paper that was awarded Best JITC Clinical/Translational Paper at #SITC2018. The paper, on durable response rate as an endpoint in cancer immunotherapy, can be found here: https://t.co/e
38 followers
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials and other recent highlights collated from #PubMedCentral by @re_figure https://t.co/qFF2Pw1E8K https://t.co/yJP1Zrhk0p